The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection-Reference-Cited by-同舟云学术

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

Published:2001-06 Issue:9 Volume:15 Page:F29-F40
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

García Felipe,Plana Montserrat,Ortiz Gabriel M.,Bonhoeffer Sebastian,Soriano Alex,Vidal Carmen,Cruceta Anna,Arnedo Mireia,Gil Cristina,Pantaleo Giuseppe,Pumarola Tomás,Gallart Teresa,Nixon Douglas F.,Miró José M.,Gatell José M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference40 articles.

1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

2. Viral dynamics in human immunodeficiency virus type 1 infection

3. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

4. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

5. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1;eLife;2022-07-19

2. Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1;2021-12-05

3. High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption;AIDS;2021-08-20

4. Assessing the impact of HIV treatment interruptions using stochastic cellular Automata;Journal of Theoretical Biology;2020-10

5. A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1–Infected Patients;JAIDS Journal of Acquired Immune Deficiency Syndromes;2020-04-15